Rheumatology / Systemic Lupus Erythematosus

Low-Dose Interleukin 2 and Its Potential in Systemic Lupus Erythematosus

patient care perspectives by George C. Tsokos, MD

Low-dose interleukin-2 (IL-2) therapy continues to be studied as a potential approach for systemic lupus erythematosus (SLE), where it may restore ......READ MORE

Systemic Lupus Erythematosus

Targeted Biologic Therapy in Systemic Lupus Erythematosus

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

Systemic Lupus Erythematosus

Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

expert roundtables by Bevra H. Hahn, MD; Joan T. Merrill, MD; and George C. Tsokos, MD

LATEST IN Rheumatology

Browse More Articles